FDA advisory panel votes 19-2 to support boosters that target both omicron and the original version of the SARS-CoV-2 virus.
Author: Karen Weintraub, USA TODAY
Youngest Americans can start getting COVID-19 vaccines Tuesday. Here’s what every parent should know.
While some parents can’t wait to vaccinate their young children against COVID-19, others remain hesitant. Your questions answered.
CDC recommends COVID-19 vaccines for youngest Americans; shots will become available as soon as Tuesday
The actions clear the way for 10 million COVID-19 vaccine doses to begin delivery and distribution to young children as soon as Tuesday.
FDA panel recommends Moderna’s COVID vaccine for the youngest kids
An FDA advisory committee found Moderna’s COVID vaccine safe and effective for children ages 6 months to 6 years old.
FDA advisers to review, likely recommend COVID-19 vaccines for young children this week
An FDA advisory committee meets for two days this week to decide whether to recommend COVID-19 vaccines for the youngest children.
FDA advisory panel to consider approving fourth COVID-19 vaccine, this one from Maryland’s Novavax
A more traditional vaccine than some of the others, Novavax’s offering might encourage some COVID-19 vaccine holdouts to get the shot, experts said.
Diabetes drug helps patients lose never-before-seen amounts of weight, new study shows
A new study of the type 2 diabetes drug tirzepatide found it also resulted in dramatic weight loss, offering hope for those struggling with obesity.
Monkeypox cases may be mistaken for a sexual transmitted disease, CDC warns
So far, 5 Americans are likely infected with monkeypox, the CDC said Monday. Health officials are trying to determine how the cases may be connected.
After omicron winter surge, CDC finds nearly 60% of all Americans and 75% of kids have been infected by the coronavirus
By the end of February, nearly 60% of all Americans and 75% of kids had antibodies indicating a prior coronavirus infection, CDC study finds.
COVID antivirals can save lives, but access is still limited. Biden announces plan to change that.
Underused COVID-19 antivirals such as Paxlovid could save more lives. The Biden administration pledges to make them more available.